
TY  - JOUR
TI  - ABSTRACTS OF THE XXIV CONGRESS OF THE INTERNATIONAL SOCIETY ON THROMBOSIS AND HAEMOSTASIS
JO  - Journal of Thrombosis and Haemostasis
JA  - J Thromb Haemost
VL  - 11
IS  - s2
SN  - 1538-7933
UR  - https://doi.org/10.1111/jth.12284
DO  - doi:10.1111/jth.12284
SP  - 1
EP  - 1322
PY  - 2013
ER  - 

TY  - JOUR
TI  - Absracts
JO  - Vox Sanguinis
VL  - 83
IS  - S2
SN  - 0042-9007
UR  - https://doi.org/10.1111/j.1423-0410.2002.tb05391.x
DO  - doi:10.1111/j.1423-0410.2002.tb05391.x
SP  - 1
EP  - 236
PY  - 2002
ER  - 

TY  - JOUR
TI  - Abstracts
JO  - BJU International
JA  - BJU Int
VL  - 123
IS  - S4
SN  - 1464-4096
UR  - https://doi.org/10.1111/bju.14748
DO  - doi:10.1111/bju.14748
SP  - 4
EP  - 51
PY  - 2019
ER  - 

TY  - JOUR
AU  - Gleissner, Christian A
AU  - Klingenberg, Roland
AU  - Nottmeyer, Winfried
AU  - Zipfel, Stephan
AU  - Sack, Falk-Udo
AU  - Schnabel, Philipp A
AU  - Haass, Markus
AU  - Dengler, Thomas J
TI  - Diagnostic efficiency of rejection monitoring after heart transplantation with cardiac troponin T is improved in specific patient subgroups
JO  - Clinical Transplantation
VL  - 17
IS  - 3
SN  - 0902-0063
UR  - https://doi.org/10.1034/j.1399-0012.2003.00050.x
DO  - doi:10.1034/j.1399-0012.2003.00050.x
SP  - 284
EP  - 291
KW  - diagnosis
KW  - heart transplantation
KW  - non-invasive
KW  - rejection
KW  - troponin T
PY  - 2003
AB  - Abstract: Cardiac troponin T (cTnT) is a cardio-specific myofibrillar protein known to be elevated early after heart transplantation and during cardiac allograft rejection. cTnT determination in heart allograft recipients showed elevated levels in patients with higher degrees of graft rejection (International Society for Heart and Lung Transplantation grades?≥3A?4). Subgroup analyses revealed demographic patient characteristics markedly improving the diagnostic efficiency of cTnT measurement for rejection monitoring, including male recipient gender, recipient age <60 yr, female donor gender and donor age?≥?33 yr. The clinical utility of these parameters was confirmed by longitudinal patient data and may help to select recipients most likely to benefit from cTnT rejection surveillance.
ER  - 

TY  - JOUR
AU  - Detterich, Jon A.
AU  - Kato, Roberta
AU  - Bush, Adam
AU  - Chalacheva, Patjanaporn
AU  - Ponce, Derek
AU  - De Zoysa, Madushka
AU  - Shah, Payal
AU  - Khoo, Michael C.
AU  - Meiselman, Herbert J.
AU  - Coates, Thomas D.
AU  - Wood, John C.
TI  - Sickle cell microvascular paradox—oxygen supply-demand mismatch
JO  - American Journal of Hematology
JA  - Am J Hematol
VL  - 94
IS  - 6
SN  - 0361-8609
UR  - https://doi.org/10.1002/ajh.25476
DO  - doi:10.1002/ajh.25476
SP  - 678
EP  - 688
PY  - 2019
AB  - Abstract We have previously demonstrated that sickle cell disease (SCD) patients maintain normal global systemic and cerebral oxygen delivery by increasing cardiac output. However, ischemic end-organ injury remains common suggesting that tissue oxygen delivery may be impaired by microvascular dysregulation or damage. To test this hypothesis, we performed fingertip laser Doppler flowmetry measurements at the base of the nailbed and regional oxygen saturation (rSO2) on the dorsal surface of the same hand. This was done during flow mediated dilation (FMD) studies in 26 chronically transfused SCD, 75 non-transfused SCD, and 18 control subjects. Chronically transfused SCD patients were studied prior to and following a single transfusion and there was no acute change in rSO2 or perfusion. Laser Doppler estimates of resting perfusion were 76% higher in non-transfused and 110% higher in transfused SCD patients, compared to control subjects. In contrast, rSO2 was 12 saturation points lower in non-transfused SCD patients, but normal in the transfused SCD patients. During cuff occlusion, rSO2 declined at the same rate in all subjects suggesting similar intrinsic oxygen consumption rates. Upon cuff release, laser doppler post occlusive hyperemia was blunted in SCD patients in proportion to their resting perfusion values. Transfusion therapy did not improve the hyperemia response. FMD was impaired in SCD subjects but partially ameliorated in transfused SCD subjects. Taken together, non-transfused SCD subjects demonstrate impaired conduit artery FMD, impaired microcirculatory post-occlusive hyperemia, and resting hypoxia in the hand despite compensated oxygen delivery, suggesting impaired oxygen supply-demand matching. Transfusion improves FMD and oxygen supply-demand matching but not microcirculation hyperemic response.
ER  - 

TY  - JOUR
TI  - PUBLICATION
JO  - Hematological Oncology
JA  - Hematol Oncol
VL  - 31
IS  - S1
SN  - 0278-0232
UR  - https://doi.org/10.1002/hon.2059
DO  - doi:10.1002/hon.2059
SP  - 201
EP  - 270
PY  - 2013
ER  - 

TY  - JOUR
TI  - Poster
JO  - Journal of Clinical Periodontology
JA  - J Clin Periodontol
VL  - 42
IS  - S17
SN  - 0303-6979
UR  - https://doi.org/10.1111/jcpe.12399
DO  - doi:10.1111/jcpe.12399
SP  - 64
EP  - 442
PY  - 2015
ER  - 

TY  - JOUR
TI  - Posters Abstracts
JO  - Research and Practice in Thrombosis and Haemostasis
JA  - Res Pract Thromb Haemost
VL  - 3
IS  - S1
SN  - 2475-0328
UR  - https://doi.org/10.1002/rth2.12229
DO  - doi:10.1002/rth2.12229
SP  - 1
EP  - 891
PY  - 2019
ER  - 

TY  - JOUR
C7  - e27989
TI  - SIOP ABSTRACTS
JO  - Pediatric Blood & Cancer
JA  - Pediatr Blood Cancer
VL  - 66
IS  - S4
SN  - 1545-5009
UR  - https://doi.org/10.1002/pbc.27989
DO  - doi:10.1002/pbc.27989
SP  - e27989
PY  - 2019
ER  - 

TY  - JOUR
TI  - Abstracts
JO  - Vox Sanguinis
VL  - 97
IS  - s1
SN  - 0042-9007
UR  - https://doi.org/10.1111/j.1423-0410.2009.01261.x
DO  - doi:10.1111/j.1423-0410.2009.01261.x
SP  - 1
EP  - 179
PY  - 2009
ER  - 

TY  - JOUR
TI  - Plenary Lectures
JO  - Pain Practice
VL  - 7
IS  - s1
SN  - 1530-7085
UR  - https://doi.org/10.1111/j.1533-2500.2007.00136_1.x
DO  - doi:10.1111/j.1533-2500.2007.00136_1.x
SP  - 1
EP  - 3
PY  - 2007
ER  - 

TY  - JOUR
AU  - Anchi, Pratibha
AU  - Khurana, Amit
AU  - Bale, Swarna
AU  - Godugu, Chandraiah
C8  - PTR-16-1468.R2
TI  - The Role of Plant-derived Products in Pancreatitis: Experimental and Clinical Evidence
JO  - Phytotherapy Research
JA  - Phytother. Res.
VL  - 31
IS  - 4
SN  - 0951-418X
UR  - https://doi.org/10.1002/ptr.5792
DO  - doi:10.1002/ptr.5792
SP  - 591
EP  - 623
KW  - pancreatitis
KW  - phytomedicine
KW  - cerulein
KW  - oxidative stress
KW  - inflammation
PY  - 2017
AB  - Pancreatitis is a gastrointestinal disease with a worldwide sharp surge during the past decade. Pancreatitis includes acute and chronic subtypes, which are graded based on the amount of pancreatic inflammation. Phytoconstituents represent a promising class of therapeutic agents with wide acceptability not only based on folk practices but sound presence of pharmacological and molecular evidences. Growing research evidence indicates that different molecular mechanisms are involved in their protective effect. Many phytoremedies have been tried for the treatment of pancreatic injuries and have shown success in preclinical animal models of pancreatitis. The literature was largely collected through PubMed and Google scholar database. A large proportion of phytochemicals targets the inflammatory cascade and modulates the overtly acting redox balance among which nuclear factor kappa-light-chain-enhancer of activated B cells is the key molecule. Inhibition of apoptosis (artemisinin, embelin), inflammasome (withaferin A), neutrophil rolling (fucoidan), Ca+2 release (caffeine), mitogen activated protein kinase (guggulsterone) and many other novel mechanisms apart from antioxidant effect have been postulated behind the protective effect of phytoconstituents. The present review deals to fill the gap of hitherto unavailable comprehensive review on various plant products screened for the treatment of pancreatitis. The possible mechanistic profile of these phytochemicals is summarized. Copyright ? 2017 John Wiley & Sons, Ltd.
ER  - 

TY  - JOUR
TI  - Abstracts of Papers to be Presented at American Association of Blood Banks. 50 Annual Meeting October 18–22, 1997
JO  - Transfusion
VL  - 37
IS  - S9
SN  - 0041-1132
UR  - https://doi.org/10.1111/j.1537-2995.1997.tb02797.x
DO  - doi:10.1111/j.1537-2995.1997.tb02797.x
SP  - 1s
EP  - 111s
PY  - 1997
ER  - 

TY  - JOUR
TI  - 2006 Abstracts: Twenty-Eighth Annual Meeting of the American Society for Bone and Mineral Research: Pennsylvania Convention Convention Center Philadelphia, Pennsylvania, USA, September 15–19, 2006
JO  - Journal of Bone and Mineral Research
JA  - J Bone Miner Res
VL  - 21
IS  - S1
SN  - 0884-0431
UR  - https://doi.org/10.1002/jbmr.5650211410
DO  - doi:10.1002/jbmr.5650211410
SP  - S402
EP  - S451
PY  - 2006
ER  - 

TY  - JOUR
TI  - Satellite Symposium
JO  - Pain Practice
VL  - 7
IS  - s1
SN  - 1530-7085
UR  - https://doi.org/10.1111/j.1533-2500.2007.00136_2.x
DO  - doi:10.1111/j.1533-2500.2007.00136_2.x
SP  - 4
EP  - 4
PY  - 2007
ER  - 

TY  - JOUR
C7  - e26772
TI  - SIOP ABSTRACTS
JO  - Pediatric Blood & Cancer
JA  - Pediatr Blood Cancer
VL  - 64
IS  - S3
SN  - 1545-5009
UR  - https://doi.org/10.1002/pbc.26772
DO  - doi:10.1002/pbc.26772
SP  - e26772
PY  - 2017
ER  - 

TY  - JOUR
TI  - Free Communication Sessions 41–60 and Poster Sessions 33–48
JO  - International Dental Journal
JA  - Int Dent J
VL  - 65
IS  - S2
SN  - 0020-6539
UR  - https://doi.org/10.1111/idj.12195
DO  - doi:10.1111/idj.12195
SP  - 108
EP  - 161
PY  - 2015
ER  - 

TY  - JOUR
TI  - Abstract
JO  - Research and Practice in Thrombosis and Haemostasis
JA  - Res Pract Thromb Haemost
VL  - 2
IS  - S1
SN  - 2475-0328
UR  - https://doi.org/10.1002/rth2.12125
DO  - doi:10.1002/rth2.12125
SP  - 1
EP  - 368
PY  - 2018
ER  - 

TY  - JOUR
TI  - Special Issue Abstracts From the American Society for Apheresis 39th Annual Meeting April 25–28, 2018, Chicago, Illinois
JO  - Journal of Clinical Apheresis
JA  - J Clin Apher
VL  - 33
IS  - 2
SN  - 0733-2459
UR  - https://doi.org/10.1002/jca.21628
DO  - doi:10.1002/jca.21628
SP  - 133
EP  - 206
PY  - 2018
ER  - 

TY  - JOUR
TI  - Topical Seminar Abstracts
JO  - Pain Practice
VL  - 7
IS  - s1
SN  - 1530-7085
UR  - https://doi.org/10.1111/j.1533-2500.2007.00136_3.x
DO  - doi:10.1111/j.1533-2500.2007.00136_3.x
SP  - 5
EP  - 15
PY  - 2007
ER  - 
